1. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021
- Author
-
Catherine E, Barrett, Alain K, Koyama, Pablo, Alvarez, Wilson, Chow, Elizabeth A, Lundeen, Cria G, Perrine, Meda E, Pavkov, Deborah B, Rolka, Jennifer L, Wiltz, Lara, Bull-Otterson, Simone, Gray, Tegan K, Boehmer, Adi V, Gundlapalli, David A, Siegel, Lyudmyla, Kompaniyets, Alyson B, Goodman, Barbara E, Mahon, Robert V, Tauxe, Karen, Remley, and Sharon, Saydah
- Subjects
Male ,Risk ,Health (social science) ,Adolescent ,Databases, Factual ,SARS-CoV-2 ,Epidemiology ,Incidence ,Health, Toxicology and Mutagenesis ,COVID-19 ,Infant ,General Medicine ,United States ,Diabetic Ketoacidosis ,Cohort Studies ,Health Information Management ,Child, Preschool ,Diabetes Mellitus ,Humans ,Female ,Full Report ,Child ,Retrospective Studies - Abstract
The COVID-19 pandemic has disproportionately affected people with diabetes, who are at increased risk of severe COVID-19.* Increases in the number of type 1 diabetes diagnoses (1,2) and increased frequency and severity of diabetic ketoacidosis (DKA) at the time of diabetes diagnosis (3) have been reported in European pediatric populations during the COVID-19 pandemic. In adults, diabetes might be a long-term consequence of SARS-CoV-2 infection (4-7). To evaluate the risk for any new diabetes diagnosis (type 1, type 2, or other diabetes)30 days
- Published
- 2022
- Full Text
- View/download PDF